Azacitidine Hikma Farmacêutica (Portugal)

Azacitidine Hikma Farmacêutica (Portugal) is a medication used for specific medical conditions. It is administered subcutaneously and is manufactured by Hikma Farmacêutica (Portugal), S.A.

Azacitidine is primarily used in the treatment of certain blood and bone marrow disorders. It works by affecting the growth of abnormal cells in the body. This medication is often prescribed for conditions that require targeted therapy to manage cell proliferation.

Common effects of Azacitidine may include fatigue, nausea, and injection site reactions. Some individuals may also experience changes in blood cell counts. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Azacitidine should be handled with care, following the prescribed guidelines for subcutaneous administration. It is essential to store the medication properly and use it as directed. Patients should be aware of potential side effects and report any severe reactions to their healthcare provider.

Azacitidine may interact with other medications, including those that affect the immune system or blood cell production. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Azacitidine.